Literature DB >> 11681498

Ophthalmic complications after surgery for nasal and sinus polyposis.

P Vassallo1, F Tranfa, R Forte, A D'Aponte, D Strianese, G Bonavolontà.   

Abstract

PURPOSE: To describe ophthalmic complications after nasal and sinus surgery.
METHODS: Four cases with orbital complications were retrospectively selected from among more than 2000 cases of orbital pathologies.
RESULTS: Motility disturbances due to extraocular muscle injury occurred in two patients after intranasal ethmoidectomy and in one patient after a Caldwell-Luc procedure. In the fourth case an orbital apex syndrome was noted after intranasal ethmoidectomies.
CONCLUSIONS: Ophthalmic complications may occur after nasal and sinus surgery, even using an endoscopic procedure. Successful handling of these complications could be reached by on their early recognition and treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11681498     DOI: 10.1177/112067210101100302

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

Review 1.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 2.  Definition and management of odontogenic maxillary sinusitis.

Authors:  Soung Min Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-03-29

Review 3.  Orbital Apex Syndrome: A Review.

Authors:  Akshay Badakere; Preeti Patil-Chhablani
Journal:  Eye Brain       Date:  2019-12-12

4.  Odontogenic rhinosinusitis and sinonasal complications of dental disease or treatment: prospective validation of a classification and treatment protocol.

Authors:  Alberto Maria Saibene; Fabio Collurà; Carlotta Pipolo; Antonio Mario Bulfamante; Paolo Lozza; Alberto Maccari; Flavio Arnone; Filippo Ghelma; Fabiana Allevi; Federico Biglioli; Matteo Chiapasco; Sara Maria Portaleone; Alberto Scotti; Roberto Borloni; Giovanni Felisati
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-27       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.